Filing Details

Accession Number:
0001209191-23-004863
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-01-25 17:20:23
Reporting Period:
2023-01-24
Accepted Time:
2023-01-25 17:20:23
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1178879 Amicus Therapeutics Inc. FOLD Pharmaceutical Preparations (2834) 200422823
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1666380 Ellen Rosenberg C/O Amicus Therapeutics
3675 Market Street
Philadelphia PA 19104
Chief Legal Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-01-24 31,839 $13.32 332,345 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 15,000 Indirect By Spouse
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  2. This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $12.89 to $13.43. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.